Clinical trials: in Egyptian Population
Chronic Obstructive Pulmonary Disease
EXACOS EG Population
Chronic obstructive pulmonary disease (COPD) is a common, progressive disease characterized by airflow obstruction which is not fully reversible.
- Trial name
- EXACOS EG (NCT06983340)
- Sponsor
- AstraZeneca
Rheumatoid Arthritis
Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population
This Post-Marketing Observational Study (PMOS) was conducted to assess the effectiveness of adalimumab on reducing synovitis (inflammation of the synovial membrane, which lines movable synovial joints, such as shoulders, elbows…
- Trial name
- NCT01782469
- Volunteers
- 16 people
- Sponsor
- AbbVie (prior sponsor, Abbott)
Chronic Hepatitis c
Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population
A single Center, Prospective Phase IV, Open-Label, Controlled, Randomized Trial comparing the efficacy, safety, and tolerability of Quadritherapy regimen (Reiferon Retard® , Ribavirin , Nitazoxanide and Alfacalcidol (Bon-One ® )…
- Trial name
- Quadritherapy (NCT01896609)
- Testing
- Reiferon Retard in Arm 1, Bon one in Arm 3, Xerovirinc in Arm 2
- Where
- Egypt
- Volunteers
- 300 people
- Sponsor
- MinaPharm Pharmaceuticals